Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

B7-H4's role "beyond the tumor".

Yu N, Li X, Zheng S, Li X.

Inflammation. 2013 Aug;36(4):941-7. doi: 10.1007/s10753-013-9624-0. Review.

PMID:
23605559
2.

Expression of costimulatory molecule B7-H4 in human malignant tumors.

Zheng X, Li XD, Wu CP, Lu BF, Jiang JT.

Onkologie. 2012;35(11):700-5. doi: 10.1159/000343638. Epub 2012 Oct 22. Review.

PMID:
23147549
3.

The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.

Zhang L, Wu H, Lu D, Li G, Sun C, Song H, Li J, Zhai T, Huang L, Hou C, Wang W, Zhou B, Chen S, Lu B, Zhang X.

Oncogene. 2013 Nov 14;32(46):5347-58. doi: 10.1038/onc.2012.600. Epub 2013 Jan 14.

4.

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.

Qian Y, Hong B, Shen L, Wu Z, Yao H, Zhang L.

Cell Tissue Res. 2013 Jul;353(1):139-51. doi: 10.1007/s00441-013-1640-8. Epub 2013 May 10.

PMID:
23660627
5.

Intracellular B7-H4 suppresses bile duct epithelial cell apoptosis in human primary biliary cirrhosis.

Chen Y, Guo G, Guo S, Shimoda S, Shroyer KR, Tang Y, Wu Y.

Inflammation. 2011 Dec;34(6):688-97. doi: 10.1007/s10753-010-9280-6.

PMID:
21120594
6.

Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.

Chen C, Qu QX, Shen Y, Mu CY, Zhu YB, Zhang XG, Huang JA.

Cancer Lett. 2012 Apr 1;317(1):99-105. doi: 10.1016/j.canlet.2011.11.017. Epub 2011 Nov 20.

PMID:
22108530
7.

B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.

Smith JB, Stashwick C, Powell DJ Jr.

Gynecol Oncol. 2014 Jul;134(1):181-9. doi: 10.1016/j.ygyno.2014.03.553. Epub 2014 Mar 20. Review.

8.

Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.

Weintraub JP, Eisenberg RA, Cohen PL.

J Immunol. 1997 Oct 15;159(8):4117-26.

PMID:
9379003
9.

Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.

Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Natsugoe S.

World J Surg. 2011 Sep;35(9):2051-7. doi: 10.1007/s00268-011-1186-4.

PMID:
21748517
10.

Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.

Dangaj D, Lanitis E, Zhao A, Joshi S, Cheng Y, Sandaltzopoulos R, Ra HJ, Danet-Desnoyers G, Powell DJ Jr, Scholler N.

Cancer Res. 2013 Aug 1;73(15):4820-9. doi: 10.1158/0008-5472.CAN-12-3457. Epub 2013 May 30.

11.

B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation.

Song H, Park G, Kim YS, Hur I, Kim H, Ryu JW, Lee HK, Cho DH, Choi IH, Lee WJ, Hur DY.

Cancer Lett. 2008 Aug 8;266(2):227-37. doi: 10.1016/j.canlet.2008.02.067. Epub 2008 Apr 15.

PMID:
18417276
12.

Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.

Park GB, Song H, Kim YS, Sung M, Ryu JW, Lee HK, Cho DH, Kim D, Lee WJ, Hur DY.

Immunology. 2009 Nov;128(3):360-8. doi: 10.1111/j.1365-2567.2009.03111.x.

13.

Could B7-H4 serve as a target to activate anti-cancer immunity?

Wang L, Heng X, Lu Y, Cai Z, Yi Q, Che F.

Int Immunopharmacol. 2016 Sep;38:97-103. doi: 10.1016/j.intimp.2016.05.020. Epub 2016 Jun 1. Review.

PMID:
27258187
14.

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation.

Wang X, Hao J, Metzger DL, Ao Z, Chen L, Ou D, Verchere CB, Mui A, Warnock GL.

PLoS One. 2012;7(1):e28232. doi: 10.1371/journal.pone.0028232. Epub 2012 Jan 4.

15.

Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.

Rathmell JC, Fournier S, Weintraub BC, Allison JP, Goodnow CC.

J Exp Med. 1998 Aug 17;188(4):651-9.

16.

B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.

Lee IF, Wang X, Hao J, Akhoundsadegh N, Chen L, Liu L, Langermann S, Ou D, Warnock GL.

Cell Immunol. 2013 Mar;282(1):1-8. doi: 10.1016/j.cellimm.2013.03.005. Epub 2013 Apr 4.

PMID:
23623902
17.

Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.

Leung J, Suh WK.

J Immunol. 2013 Jun 15;190(12):6651-61. doi: 10.4049/jimmunol.1201242. Epub 2013 May 17.

18.

Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas.

Chen C, Zhu YB, Shen Y, Zhu YH, Zhang XG, Huang JA.

J Immunother. 2012 May;35(4):354-8. doi: 10.1097/CJI.0b013e31824212c4.

PMID:
22495393
19.

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L.

Cancer Gene Ther. 2004 Mar;11(3):237-48.

PMID:
14739939

Supplemental Content

Support Center